Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

Rhea-AI Summary

Madrigal Pharmaceuticals (NASDAQ: MDGL) announced its participation in the upcoming Canaccord Genuity 45th Annual Growth Conference. The company's presentation is scheduled for Tuesday, August 12, 2025, at 10:30 A.M. EDT.

Investors can access the live webcast through the provided link or via Madrigal's Investor Relations Events and Presentations page. A replay will be made available following the event.

News Market Reaction

+1.09%

1 alert

+1.09% News Effect

On the day this news was published, MDGL gained 1.09%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

CONSHOHOCKEN, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the Canaccord Genuity 45^th Annual Growth Conference on Tuesday, Aug. 12, 2025 at 10:30 A.M. EDT.

The presentation will be webcast live and may be accessed here or by visiting Madrigal’s Investor Relations Events and Presentations page. A replay of the webcast will be available after the event.

About Madrigal
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by the FDA for the treatment of MASH with moderate to advanced fibrosis (consistent with stages F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (consistent with stage F4c). For more information, visit www.madrigalpharma.com.

Investor Contact
Tina Ventura, IR@madrigalpharma.com

Media Contact
Christopher Frates, media@madrigalpharma.com

FAQ

When is Madrigal Pharmaceuticals (MDGL) presenting at the Canaccord Genuity Conference 2025?

Madrigal Pharmaceuticals will present at the conference on Tuesday, August 12, 2025 at 10:30 A.M. EDT.

How can investors watch Madrigal Pharmaceuticals' (MDGL) Canaccord conference presentation?

Investors can watch the presentation via live webcast through the provided link or on Madrigal's Investor Relations Events and Presentations page. A replay will be available after the event.

What is the name of the conference where Madrigal Pharmaceuticals (MDGL) will present?

Madrigal Pharmaceuticals will present at the Canaccord Genuity 45th Annual Growth Conference.

Will there be a replay available of Madrigal Pharmaceuticals' (MDGL) conference presentation?

Yes, a replay of the webcast will be made available after the event on Madrigal's website.